Binder profile
ZINC28711394
Virtual-screening candidate from ZINC.
Bound to: PA3542 — alginate biosynthesis protein Alg44
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC28711394- UniProt (similar protein)
Q9HY69- Tanimoto
- 0.706
- Target protein
- PA3542
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- MW ≤ 500 Da 415.3
- LogP ≤ 5 -0.17
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 11
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 180.9
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CCCC(=O)O[C@@H]1[C@@H]2O[P@](=O)(O)OC[C@H]2O[C@H]1n1cnc2c(=O)[nH]c(N)nc21CCCC(=O)O[C@@H]1[C@@H]2O[P@](=O)(O)OC[C@H]2O[C@H]1n1cnc2c(=O)[nH]c(N)nc21
InChI=1S/C14H18N5O8P/c1-2-3-7(20)26-10-9-6(4-24-28(22,23)27-9)25-13(10)19-5-16-8-11(19)17-14(15)18-12(8)21/h5-6,9-10,13H,2-4H2,1H3,(H,22,23)(H3,15,17,18,21)/t6-,9-,10-,13-/m1/s1InChI=1S/C14H18N5O8P/c1-2-3-7(20)26-10-9-6(4-24-28(22,23)27-9)25-13(10)19-5-16-8-11(19)17-14(15)18-12(8)21/h5-6,9-10,13H,2-4H2,1H3,(H,22,23)(H3,15,17,18,21)/t6-,9-,10-,13-/m1/s1
WDVIGZGWJSZZDQ-ZRFIDHNTSA-NWDVIGZGWJSZZDQ-ZRFIDHNTSA-N
Provenance
Annotation context from LigQ_2, the internal TPW step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Query
- C2E
- Homolog
- Q9HY69
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC28711394 →
- ZINC ZINC20 ZINC28711394 →
- UniProt UniProt Q9HY69 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC28711394”) →
Other binders for this protein
Quick navigation to other ligands bound to PA3542.
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).